Hyunsook Kim Selected Research

Hyunsook Kim Research Topics

Disease

15	Insulin Resistance 01/2022 - 07/2002
11	Body Weight (Weight, Body) 01/2022 - 07/2010
6	Obesity 01/2022 - 01/2017
6	Inflammation (Inflammations) 12/2021 - 04/2010
6	Weight Gain 11/2020 - 07/2010
6	Type 2 Diabetes Mellitus (MODY) 04/2009 - 07/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 11/2012
3	Fatty Liver 11/2020 - 07/2010
3	Neoplasms (Cancer) 12/2014 - 08/2007
2	Renal Insufficiency (Renal Failure) 03/2021 - 01/2021
2	Heart Failure 03/2021 - 01/2021
2	Chronic Renal Insufficiency 01/2021 - 05/2020
2	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 01/2015
2	Metabolic Diseases (Metabolic Disease) 11/2020 - 11/2018
2	Adenocarcinoma 12/2014 - 11/2012
2	Dyslipidemias (Dyslipidemia) 11/2012 - 11/2004
2	Hyperglycemia 11/2004 - 07/2002
1	Hemolysis 01/2022
1	Dysbiosis 01/2022
1	Death (Near-Death Experience) 01/2022
1	Fibrosis (Cirrhosis) 03/2021
1	Persistent Vegetative State (Vegetative State) 01/2021
1	Hypoalbuminemia 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Anemia 01/2021
1	Diabetes Mellitus 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Foodborne Diseases 08/2020
1	Vascular Calcification 05/2020
1	Vibrio Infections 01/2020
1	Sepsis (Septicemia) 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Constipation 01/2019
1	Glucose Intolerance 11/2018
1	Immune System Diseases (Immune Disorders) 11/2018
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 11/2012
1	Hypercholesterolemia 11/2012

Drug/Important Bio-Agent (IBA)

10	CholesterolIBA 11/2020 - 04/2010
10	Insulin (Novolin)FDA Link 01/2019 - 07/2002
9	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 07/2002
8	LipidsIBA 01/2019 - 07/2003
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2004
5	Bile Acids and Salts (Bile Acids)IBA 01/2019 - 04/2010
5	IGF Type 1 Receptor (IGF 1 Receptor)IBA 03/2005 - 07/2002
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2017
4	Fatty Acids (Saturated Fatty Acids)IBA 08/2020 - 07/2010
4	microcrystalline celluloseIBA 08/2020 - 04/2010
3	PrebioticsIBA 01/2022 - 11/2018
3	LDL CholesterolIBA 11/2017 - 07/2013
2	Galectin 3 (LGALS3)IBA 03/2021 - 01/2021
2	FlavonoidsIBA 08/2020 - 01/2016
2	PolyphenolsIBA 08/2020 - 11/2018
2	Tocopherols (Tocopherol)IBA 12/2014 - 11/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 12/2014 - 03/2005
2	Hypromellose DerivativesIBA 07/2013 - 09/2012
2	beta-GlucansIBA 07/2010 - 04/2009
1	GelatinasesIBA 01/2022
1	GelatinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	S-layer proteinsIBA 12/2021
1	DiureticsIBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Sodium Hypochlorite (Clorox)IBA 01/2021
1	calcium hypochloriteIBA 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	pterostilbeneIBA 11/2020
1	Blood Glucose (Blood Sugar)IBA 11/2020
1	FructoseIBA 08/2020
1	Enterotoxins (Enterotoxin)IBA 08/2020
1	WD repeat containing planar cell polarity effectorIBA 05/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	ORALIT (ORS)IBA 01/2019
1	ProcalcitoninIBA 01/2019
1	AntioxidantsIBA 01/2019
1	zonulinIBA 11/2018
1	PropionatesIBA 11/2018
1	InflammasomesIBA 11/2018
1	VLDL CholesterolIBA 11/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	CeramidesIBA 01/2016
1	gintoninIBA 01/2015
1	Glucose-6-PhosphateIBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	OilsIBA 12/2014
1	HDL LipoproteinsIBA 12/2014
1	GlucocorticoidsIBA 07/2013
1	Insulin-Like PeptidesIBA 11/2012
1	Dietary Fats (Dietary Fat)IBA 11/2012
1	CelluloseIBA 11/2012
1	Dietary Fiber FDA Link 09/2012
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 09/2010
1	N-Methylaspartate (NMDA)IBA 09/2010

Therapy/Procedure

2	Therapeutics 03/2021 - 01/2021
1	Terminal Care (Care, Terminal) 01/2022
1	Nursing Care 01/2022
1	Renal Dialysis (Hemodialysis) 03/2021